Genetec Technology Bhd.

Genetec Technology Bhd.'s next confirmed earnings release is scheduled for December 2, 2026.

As of June 30, 2026, Genetec Technology Bhd. has 773.12M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 2.34, and the price-to-book ratio stands at 0.83.

These figures are as of June 30, 2026. The EV/Sales ratio of 2.92 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of June 30, 2026, Genetec Technology Bhd. maintains a current ratio of 2.10, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 35.01, indicating elevated leverage, while an interest coverage ratio of -35.44 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Genetec Technology Bhd. posted a negative return on equity (ROE) of -40.10, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -31.13, reflecting losses generated across the asset base. Inventory turnover of 16.03 indicates how many times Genetec Technology Bhd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 23, 2026, Genetec Technology Bhd.'s stock has declined approximately 49.52% over the past 52 weeks. The 50-day moving average sits at 0.33, while the 200-day moving average is 0.28.

Over the twelve months ended June 30, 2026, Genetec Technology Bhd. posted a gross margin of -113.15, reflecting its pricing power and cost economics. The operating margin of -136.78 and net profit margin of -140.94 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -7.65: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -25.06, meaning Genetec Technology Bhd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Genetec Technology Bhd.'s most recent stock split took place on January 7, 2022 with a 1:13 split ratio.

As of June 30, 2026, Genetec Technology Bhd. has an Altman Z-Score of 0.77, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.